Skip to main content
VERICI DX PLC logo

VERICI DX PLC — Investor Relations & Filings

Ticker · VRCI ISIN · GB00BM8HZD43 LEI · 213800FI5WE4FVQ3G645 IL Real estate activities
Filings indexed 192 across all filing types
Latest filing 2021-01-11 Regulatory Filings
Country GB United Kingdom
Listing IL VRCI

About VERICI DX PLC

https://www.vericidx.com/

Verici Dx is an immuno-diagnostics company developing and commercializing a suite of proprietary tests for the kidney transplant market. The company's platform utilizes artificial intelligence-assisted transcriptomic analysis of RNA signatures to provide data-driven insights to clinicians. These tests are designed to decipher the body's immune response and other biological signals, enabling personalized risk assessment for organ injury, rejection, and graft failure. The goal is to assist clinicians in medical management throughout the transplant process, from pre-transplant to late-stage care, ultimately aiming to improve patient outcomes and long-term graft survival.

Recent filings

Filing Released Lang Actions
Additional patent licence with Mount Sinai
Regulatory Filings Classification · 95% confidence The document begins with 'RNS Number' and is dated January 11, 2021. It announces an 'Additional patent licence with Mount Sinai' and discusses strengthening the patent portfolio related to diagnostic assays (Clarava™ and Tuteva™). The content is a corporate announcement regarding a strategic development (IP licensing) rather than a full financial report (10-K, IR) or a standard earnings release (ER). Since it is a formal announcement distributed via RNS (London Stock Exchange's news service) that doesn't fit the specific categories like M&A (TAR), Capital Change (CAP), or Director Dealing (DIRS), it falls best under the general Regulatory Filings category (RNS) or potentially a general announcement, but RNS is the most appropriate fit for LSE-distributed news items that aren't otherwise classified.
2021-01-11 English
Appointment of Senior Director
Board/Management Information Classification · 99% confidence The document begins with an 'RNS Number' and is dated December 23, 2020. The content announces the appointment of a Senior Director of Clinical Trial Operations and provides updates on preparatory phases for validation trials. This type of announcement, which is a specific corporate action (personnel change) released via the Regulatory News Service (RNS) system of the London Stock Exchange, fits best under the general 'Regulatory Filings' category, as there is no specific code for 'Personnel Appointment'. While it relates to management, it is not a broad MANG announcement about the board structure, but a specific operational hire announcement distributed via RNS. Given the RNS header and the nature of the announcement, RNS is the most appropriate classification.
2020-12-23 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is titled 'TR-1: Standard form for notification of major holdings' and is issued via 'RNS Number : 1834F' on '12 November 2020'. It details changes in voting rights percentages for specific shareholders (Oryx International Growth Fund Limited, North Atlantic Smaller Companies Investment Trust PLC, and Harwood Capital LLP) related to the issuer VERICI DX PLC. This structure and content precisely match the definition of a notification regarding changes in significant share ownership levels, which corresponds to the Major Shareholding Notification category (MRQ). Although it is distributed via RNS, the specific content dictates the classification over the general RNS fallback.
2020-11-12 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains fields related to voting rights, shareholder positions, and thresholds crossed. It is filed via 'RNS Number' and mentions the 'FCA' (Financial Conduct Authority). This structure is characteristic of a regulatory filing notifying a change in significant share ownership. The definition for 'Major Shareholding Notification' (MRQ) fits this perfectly, as it covers 'Notification of changes in significant share ownership levels (crossing thresholds)'. Although it is an RNS filing, MRQ is the more specific category.
2020-11-12 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains fields related to the 'Identity of the issuer', 'Reason for the notification' (acquisition/disposal of voting rights), details of the 'person subject to the notification obligation' (Unicorn Asset Management Limited), and the resulting 'Total positions' as a percentage of voting rights (3.17%). This structure is characteristic of a regulatory filing mandated when a shareholder's stake crosses a specific threshold. The presence of 'RNS Number' and reference to the 'FCA' (Financial Conduct Authority) confirms it is a regulatory disclosure. This type of filing, reporting changes in significant share ownership, maps directly to the Major Shareholding Notification category.
2020-11-05 English
AIM Admission & First Day of Dealings
Regulatory Filings Classification · 98% confidence The document is an RNS announcement from Verici Dx PLC dated November 3, 2020. The primary subject is the 'Admission to trading on AIM & First Day of Dealings' following a successful fundraising (£14.5 million). This announcement details the completion of a capital raising event (Placing, Subscription, Restricted Offer) and the subsequent listing/commencement of trading on the AIM market. This clearly falls under the category of announcing financing activities and capital structure changes, specifically related to an Initial Public Offering (IPO) process which involves fundraising and admission. The most fitting category is 'Capital/Financing Update' (CAP). While it is distributed via RNS, the core content is about the capital event, not a general regulatory update or a report publication announcement.
2020-11-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.